ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/05/2026
Back to search
Official data from USPTO
UROGEN PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
05/06/2026
Trademark type
Combined
Nice classes
42
Filing date
08/29/2018
Registration date
10/22/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/01/2025
Last transaction
05/06/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2018-11-00
First use in commerce
2018-11-00
Drawing code
3
Owner type
03
Owner location
Ra'anana, IL
Examiner
CORDOVA, RAUL
Current location
Historical data usage
Mark description
The mark consists of of the word "UroGen", beneath it the word "Pharma", and to the left a stylized cross-sectional image of a human kidney. The letters "Gen" and the exterior of the kidney are in dark blue; the letters "Uro", the word "Pharma" and the interior of the kidney are in light blue.
Holders and representatives
Holders
UROGEN PHARMA LTD.
UROGEN PHARMA LTD.
Representatives
Peter J. Willsey Kilpatrick Townsend & Stockton LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Clinical research and development services in the field of uro-oncology
Publications
History of USPTO decisions and trademark events.
48 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/01/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/01/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/01/2025
E815
TEAS SECTION 8 & 15 RECEIVED
08/19/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/10/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/10/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/10/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/22/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/19/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/19/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/19/2021
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
06/19/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/21/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/21/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/21/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/21/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/21/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/21/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/17/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/16/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/14/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/14/2019
IUAF
USE AMENDMENT FILED
08/16/2019
EISU
TEAS STATEMENT OF USE RECEIVED
08/16/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/09/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/27/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/27/2019
NPUB
NOTICE OF PUBLICATION
05/17/2019
PUBO
PUBLISHED FOR OPPOSITION
05/14/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/29/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/29/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2019
ALIE
ASSIGNED TO LIE
03/29/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/25/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/19/2018
GNRT
NON-FINAL ACTION E-MAILED
12/19/2018
CNRT
NON-FINAL ACTION WRITTEN
12/19/2018
DOCK
ASSIGNED TO EXAMINER
12/12/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/07/2018
NWAP
NEW APPLICATION ENTERED
09/01/2018
Continuous trademark protection
Get notified about every new filing that threatens UROGEN PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.